Vaccine Breakthrough: BCG Offers Broader Virus Defense Including COVID-19 – New Study Reveals!
Montreal, Canada – As flu season collides with a rise in strep A cases and ongoing concerns about COVID-19, researchers at the Research Institute of the McGill University Health Centre have made a groundbreaking discovery. A recent study published in Nature Immunology sheds light on a century-old tuberculosis vaccine, Bacillus Calmette Guérin (BCG), and its unexpected ability to protect against influenza A. The researchers uncovered a previously unknown mechanism in the BCG vaccine that extends …